{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:57:18Z","timestamp":1790539038167,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006188","name":"Einstein Foundation Berlin","doi-asserted-by":"publisher","award":["EPP-BUA-2022-697"],"award-info":[{"award-number":["EPP-BUA-2022-697"]}],"id":[{"id":"10.13039\/501100006188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP223fa627004"],"award-info":[{"award-number":["JP223fa627004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K17329"],"award-info":[{"award-number":["JP22K17329"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJPR22R3"],"award-info":[{"award-number":["JPMJPR22R3"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Government of Japan Ministry of Education Culture Sports Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129079","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:21:31Z","timestamp":1787779291000},"page":"129079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparing the potential impacts of seasonal immunisation against year-round immunisation to prevent RSV infant hospitalisations in Japan: A modelling study"],"prefix":"10.1016","volume":"91","author":[{"given":"Ayaka","family":"Monoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Kriznar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Flasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10340","key":"10.1016\/j.vaccine.2026.129079_bb0005","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2026.129079_bb0010","series-title":"WHO position paper on immunization to protect infants against respiratory syncytial virus disease, May 2025 [Internet]","first-page":"193","author":"World Health Organization","year":"2025"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129079_bb0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","volume":"7","author":"Sim\u00f5es","year":"2023","journal-title":"The Lancet Child & Adolescent Health"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129079_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/AOG.0000000000005816","article-title":"Efficacy, safety, and immunogenicity of the MATISSE (maternal immunization study for safety and efficacy) maternal Respiratory Syncytial Virus prefusion F protein vaccine trial","volume":"145","author":"Sim\u00f5es","year":"2025","journal-title":"Obstetrics & Gynecology"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129079_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.0380","article-title":"Estimated effectiveness of Nirsevimab against Respiratory Syncytial Virus","volume":"8","author":"Xu","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.129079_bb0030","unstructured":"VIEW-hub by IVAC [Internet]. [cited 2025 Nov 22]. Available from: https:\/\/view-hub.org\/vaccine\/rsv."},{"key":"10.1016\/j.vaccine.2026.129079_bb0035","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.vaccine.2026.129079_bb0045","author":"UK Health Security Agency"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129079_bb0050","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1097\/INF.0000000000004936","article-title":"Current challenges and future directions for RSV Prevention strategies in Japan","volume":"44","author":"Ogimi","year":"2025","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129079_bb0055","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/infdis\/jiab606","article-title":"Understanding the potential drivers for respiratory syncytial virus rebound during the coronavirus disease 2019 pandemic","volume":"225","author":"Li","year":"2022","journal-title":"J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2026.129079_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.15585\/mmwr.mm7214a1","volume":"72","author":"Hamid","year":"2023","journal-title":"sin. MMWR Morb Mortal Wkly Rep."},{"issue":"11","key":"10.1016\/j.vaccine.2026.129079_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.15585\/mmwr.mm7411a1","article-title":"Human metapneumovirus seasonality and co-circulation with respiratory syncytial virus - United States, 2014-2024","volume":"74","author":"Jobe","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129079_bb0070","author":"National Institute of Infectious Diseases, Japan Institute for Health Security"},{"key":"10.1016\/j.vaccine.2026.129079_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66184-y","article-title":"Interplay between climate and childhood mixing can explain a sudden shift in RSV seasonality in Japan","author":"Park","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.129079_bb0080","author":"Working Group for the Revision of the Guidelines on the Use of Palivizumab in Japan"},{"key":"10.1016\/j.vaccine.2026.129079_bb0085","author":"Ministry of Health, Labour and Welfare (Japan)"},{"key":"10.1016\/j.vaccine.2026.129079_bb0090","first-page":"1","year":"2024","journal-title":"Japan Pediatric Association, Immunization and infectios disease prevention committee"},{"key":"10.1016\/j.vaccine.2026.129079_bb0095","author":"Ministry of Health, Labour and Welfare (Japan)"},{"key":"10.1016\/j.vaccine.2026.129079_bb0100","author":"Japan Pediatric Society, Committee on Vaccination and Infectious Disease Control"},{"key":"10.1016\/j.vaccine.2026.129079_bb0105","author":"Pharmaceuticals and Medical Devices Agency"},{"key":"10.1016\/j.vaccine.2026.129079_bb0110","author":"Tokyo Neonatal Medical Council"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129079_bb0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.7883\/yoken.JJID.2017.261","article-title":"Respiratory Syncytial Virus surveillance system in Japan: assessment of recent trends, 2008\u20132015","volume":"71","author":"Kanou","year":"2018","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129079_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/ped.14957","article-title":"Epidemiology of respiratory syncytial virus in Japan: a nationwide claims database analysis","volume":"64","author":"Kobayashi","year":"2022","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2026.129079_bb0135","unstructured":"Ministry of Health, Labour and Welfare (Japan). RS virus disease Notification Requirements for Physicians and Veterinarians under the Infectious Diseases Control Act (Japan) [Internet]. [cited 2026 Apr 29]. Available from: https:\/\/www.mhlw.go.jp\/bunya\/kenkou\/kekkaku-kansenshou11\/01-05-15.html."},{"key":"10.1016\/j.vaccine.2026.129079_bb0140","unstructured":"Japan Institute for Health Security\/National Institute of Infectious, Diseases\/Department of Infectious Disease Surveillance. Acute Respiratory Infection Surveillance Weekly Report: Epidemiologic Situational Awareness [Internet]. [cited 2026 Jan 7]. Available from: https:\/\/id-info.jihs.go.jp\/surveillance\/idss\/content\/teiten_ARI\/ARI_2025w18.pdf."},{"key":"10.1016\/j.vaccine.2026.129079_bb0145","first-page":"1","year":"2024","journal-title":"Tokyo Neonatal Medical Concil"},{"key":"10.1016\/j.vaccine.2026.129079_bb0150","author":"Kanagawa Prefectural Branch, Japan Pediatric Society"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129079_bb0155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12916-020-01802-8","article-title":"Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis","volume":"18","author":"Hodgson","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129079_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004625","article-title":"The benefits and risks of maternal RSV vaccination on mortality in South Africa: a modeling study","volume":"23","author":"Monoi","year":"2026","journal-title":"PLoS Med"},{"issue":"16","key":"10.1016\/j.vaccine.2026.129079_bb0165","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7416a1","article-title":"Interim evaluation of respiratory syncytial virus hospitalization rates among infants and young children after introduction of respiratory syncytial virus prevention products \u2014 United States, October 2024\u2013February 2025","volume":"74","author":"Patton","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.129079_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00742-X","article-title":"Impact of universal nirsevimab prophylaxis in infants on hospital and primary care outcomes across two respiratory syncytial virus seasons in Galicia, Spain (NIRSE-GAL): a population-based prospective observational study","author":"Razzini","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2026.129079_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2025.101175","article-title":"The seasonality of respiratory syncytial virus and its associations with meteorological factors in Hong Kong, 2014-2023","volume":"21","author":"Xiong","year":"2025","journal-title":"One Health"},{"key":"10.1016\/j.vaccine.2026.129079_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1435294","article-title":"Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study","volume":"14","author":"Kuang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2026.129079_bb0190","article-title":"Cost-effectiveness of Nirsevimab for respiratory syncytial virus in infants and young children","author":"Hutton","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2026.129079_bb0195","author":"Direcci\u00f3n Xeral de Sa\u00fade P\u00fablica"},{"issue":"32","key":"10.1016\/j.vaccine.2026.129079_bb0200","doi-asserted-by":"crossref","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","article-title":"Use of Clesrovimab for prevention of severe respiratory syncytial virus-associated lower respiratory tract infections in infants: recommendations of the advisory committee on immunization practices - United States, 2025","volume":"74","author":"Moulia","year":"2025","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129079_bb0205","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062574","article-title":"Respiratory Syncytial Virus-associated hospitalizations among children <5 years old: 2016 to 2020","volume":"153","author":"Curns","year":"2024","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129079_bb0210","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"N Engl J Med"},{"issue":"45","key":"10.1016\/j.vaccine.2026.129079_bb0215","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.45.2500816","article-title":"Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged <\u00a024\u00a0months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025","volume":"30","author":"Savulescu","year":"2025","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2026.129079_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00233-6","article-title":"Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study","author":"Torres","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2026.129079_bb0225","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2502984","article-title":"Clesrovimab for Prevention of RSV Disease in healthy infants","volume":"393","author":"Zar","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129079_bb0230","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1016\/S2214-109X(19)30264-5","article-title":"Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis","volume":"7","author":"Li","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2026.129079_bb0235","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000004878","article-title":"Maternal immunization with RSVpreF vaccine: effectiveness in preventing respiratory syncytial virus\u2013associated hospitalizations in infants under 6 months in Argentina: multicenter case\u2013control study","author":"Gentile","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.129079_bb0245","author":"Haute Autorit\u00e9 de Sant\u00e9"},{"issue":"10328","key":"10.1016\/j.vaccine.2026.129079_bb0250","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:31:58Z","timestamp":1790537518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S0264410X26008881"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the potential impacts of seasonal immunisation against year-round immunisation to prevent RSV infant hospitalisations in Japan: A modelling study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129079"}}